Table 1.
Patient’s clinical, laboratory, and instrumental parameters.
| Clinical data | Results |
| Gender | Male |
| Age (years) | 47 |
| Height (cm) | 176 |
| Weight (kg) | 145 |
| Body mass index (kg/m2) | 46.8 |
| Systolic blood pressure (mmHg) | 140 |
| Diastolic blood pressure (mmHg) | 80 |
| Risk factors | Hypertension, diabetes, hyperlipidemia |
| Laboratory data | |
| Glucose (mg/dL) | 203 (nv: 60–110) |
| Urea (mg/dL) | 28 (nv: 10–50) |
| Creatinine (mg/dL) | 0.83 (nv: 0.8–1.4) |
| Total-cholesterol (mg/dL) | 154 (nv: <200) |
| HDL-cholesterol (mg/dL) | 33 (nv: >45) |
| LDL-cholesterol (mg/dL) | 99 (nv: <130) |
| Triglycerides (mg/dL) | 111 (nv: <150) |
| Serum iron (mg/dL) | 89 (nv: 50–170) |
| ALT (UI/L) | 61 (nv: <50) |
| AST (UI/L) | 50 (nv: <50) |
| CPK (UI/L) | 112 (nv: 0–173) |
| CPK-MB (UI/L) | 11 (nv: 7–25) |
| LDH (UI/L) | 242 (nv: 135–460) |
| Sodium (mmol/L) | 138 (nv: 136–146) |
| Potassium (mmol/L) | 4.0 (nv: 3.5–5.1) |
| Calcium (mg/dL) | 9.6 (nv: 8.4–10.2) |
| White blood cells count (x103/uL) | 11.9 (nv: 5.2–12.4) |
| Red blood cells count (x103/uL) | 5.40 (nv: 4.2–5.2) |
| Hemoglobin (g/dL) | 15.8 (nv: 12–15) |
| Hematocrit (%) | 47 (nv: 37–47) |
| Platelet count (x103/uL) | 219 (nv: 130–400) |
| Instrumental data | |
| Left ejection fraction (%) | 50 |
| Wall motion abnormalities | Mild septal hypokinesia |
| Number of stents | 2 |
| Stents size (diameter x length mm) | 3.0 × 20 and 3.0 × 12 |
| Type of stents | Platinum–chromium everolimus-eluting |
| Minimum lumen area (mm2) | 7.5 |
| Minimum lumen diameter (mm) | 3.0 × 3.2 |
| Diameter stenosis (%) | 30 |
nv, normal values; HDL, high-density lipoprotein; LDL, low-density lipoprotein; ALT, alanine transaminase; AST, aspartate transaminase; CPK, creatine phosphokinase; LDH, lactate dehydrogenase.